SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLife Settlemen Regulatory News (LSAA)

Share Price Information for Life Settlemen (LSAA)

Share Price is delayed by 15 minutes
Get Live Data
1.795    0.00 (0.00%)
Bid:
1.77
Ask:
1.82
Spread: 0.05 (2.825%)
Market Cap: $75.42m
LSAA Live PriceLast checked at - London Stock Exchange

Intraday Life Settlemen Share Chart

Statement re agreement to reduce performance fee

30 Jun 2022 07:00

RNS Number : 7164Q
Life Settlement Assets PLC
30 June 2022
 

 

LIFE SETTLEMENT ASSETS PLC (the "Company" or "LSA")

AGREEMENT OF REDUCED ACL PERFORMANCE FEE

30 June 2022

As referred to in the Company's annual results for the year ended 31 December 2021, LSA has been in discussions with Acheron Capital Limited ("ACL") regarding the re-negotiation of the performance fee payable to ACL, which is currently defined as an amount equal to 20% of the total distributions made by the Company over an agreed hurdle rate. Agreement has now been reached with ACL that once the current litigation process with one of the policy trustees has been resolved, which is expected to occur during 2022, the performance fee will be reduced from 20% as described above to 10% over the existing hurdle rate.

The resolution of the legal dispute is expected to be accompanied by a judicially approved sale of the policies in the relevant trustee portfolio. The completion of such a sale process, including LSA`s participation therein whether successful or not, would mark the end of LSA`s need to accumulate cash to purchase the relevant policies, so enabling LSA to resume further distributions to Shareholders. Assuming resolution of the dispute, following the first such distribution LSA has agreed to make a one-off payment to ACL of any accrued performance fee payable to ACL held by the Company in excess of $1m, based on the 2022 financial results and subject to the cash requirements of the business. As at 31 December 2021 the accrued performance fee stood at $2.8m. However, in acknowledgement of the significant work that ACL has had to perform with regard to engagement with the legal dispute over a long period, the Directors of LSA have agreed to make an immediate advance to ACL, subject to an agreed clawback mechanism, of $0.5m which will be credited against any amount to be paid under the above one-off payment arrangement, following the publication of the 2022 financial results.

 

For further information contact

Acheron Capital Limited (Investment Manager)

Jean-Michel Paul

020 7258 5990

 

Shore Capital (Financial Adviser and Broker)

Robert Finlay

020 7408 4090

 

ISCA Administration Services Limited

Company Secretary

Tel: 01392 487056

 

Notes to Editors

Life Settlement Assets PLC is a closed-ended investment trust company which invests in, and manages, portfolios of whole and fractional interests in life settlement policies issued by life insurance companies operating predominantly in the United States. The Company seeks to generate long-term returns for investors by investing in the life settlement market, through each of the separate Share Classes. The Company aims to manage its investment in portfolios of life settlement products so that the realised value of the policy maturities exceeds the aggregate cost of acquiring the policies, ongoing premiums, management fees and other operational costs.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STRSEAFWUEESEFM
Date   Source Headline
1st Apr 202510:09 amRNSTotal Voting Rights
28th Mar 202511:45 amRNSPortfolio Update - Update on MBC finalisation
18th Mar 20257:00 amRNSTransaction in Own Shares
11th Mar 20252:01 pmRNSNet Asset Value(s)
3rd Mar 202510:03 amRNSTotal Voting Rights
5th Feb 20254:58 pmRNSTransaction in Own Shares
3rd Feb 20258:51 amRNSTotal Voting Rights
16th Jan 202510:33 amRNSNet Asset Value(s)
6th Jan 20257:00 amRNSTransaction in Own Shares
2nd Jan 20257:00 amRNSTotal Voting Rights
27th Dec 20247:00 amRNSTransaction in Own Shares
18th Dec 20245:10 pmRNSTransaction in Own Shares
16th Dec 20247:00 amRNSTransaction in Own Shares
13th Dec 20247:00 amRNSNet Asset Value(s)
3rd Dec 20247:00 amRNSTransaction in Own Shares
2nd Dec 20249:24 amRNSDirector Declaration
22nd Nov 20242:05 pmRNSNet Asset Value(s)
1st Nov 20247:30 amRNSTotal Voting Rights
1st Nov 20247:01 amRNSTransaction in Own Shares
23rd Oct 20247:00 amRNSTransaction in Own Shares
7th Oct 20247:42 amRNSTransaction in Own Shares
7th Oct 20247:00 amRNSNet Asset Value(s)
1st Oct 20249:41 amRNSTotal Voting Rights
20th Sep 20245:27 pmRNSTransaction in Own Shares
20th Sep 20247:00 amRNSHalf-year Report
16th Sep 20247:00 amRNSNet Asset Value(s)
29th Aug 20247:00 amRNSStatement re Update on MBC settlement
12th Aug 20245:16 pmRNSHolding(s) in Company
2nd Aug 20241:15 pmRNSNet Asset Value(s)
1st Aug 20248:09 amRNSTotal Voting Rights
30th Jul 20246:17 pmRNSHolding(s) in Company
29th Jul 20244:51 pmRNSHolding(s) in Company
25th Jul 20247:00 amRNSTransaction in Own Shares
23rd Jul 20247:00 amRNSTransaction in Own Shares
16th Jul 20248:15 amRNSTransaction in Own Shares
15th Jul 20247:00 amRNSTransaction in Own Shares
12th Jul 20247:00 amRNSTransaction in Own Shares
9th Jul 20247:00 amRNSTransaction in Own Shares
8th Jul 20247:00 amRNSNet Asset Value(s)
1st Jul 202410:33 amRNSTotal Voting Rights
28th Jun 20247:00 amRNSTransaction in Own Shares
27th Jun 20247:00 amRNSTransaction in Own Shares
26th Jun 20247:00 amRNSTransaction in Own Shares
25th Jun 20247:00 amRNSTransaction in Own Shares
24th Jun 20247:57 amRNSTransaction in Own Shares
21st Jun 20247:00 amRNSTransaction in Own Shares
20th Jun 20247:00 amRNSTransaction in Own Shares
18th Jun 20242:49 pmRNSAGM Statement
13th Jun 20241:13 pmRNSNet Asset Value(s)
13th Jun 20247:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.